Catalyst Wire Dossier Catalyst Wire Dossier

JHM03

JHM03 · JHM BioPharma (Tonghua) Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JHM03, covering 2025-04-02 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients With Upper Limb Spasticity [Phase 1, Phase 2]

See pricing